Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Debt Ratio (2016 - 2025)

ImmunityBio (IBRX) has disclosed Debt Ratio for 12 consecutive years, with 0.65 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 12.92% to 0.65 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.65 through Dec 2025, down 12.92% year-over-year, with the annual reading at 0.65 for FY2025, 12.92% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.65 at ImmunityBio, up from 0.61 in the prior quarter.
  • The five-year high for Debt Ratio was 1.5 in Q1 2021, with the low at 0.24 in Q2 2024.
  • Average Debt Ratio over 5 years is 0.83, with a median of 0.76 recorded in 2025.
  • The sharpest move saw Debt Ratio skyrocketed 22305.32% in 2021, then crashed 47.21% in 2022.
  • Over 5 years, Debt Ratio stood at 1.45 in 2021, then plummeted by 43.96% to 0.82 in 2022, then crashed by 62.21% to 0.31 in 2023, then soared by 141.07% to 0.74 in 2024, then dropped by 12.92% to 0.65 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.65, 0.61, and 0.76 for Q4 2025, Q3 2025, and Q2 2025 respectively.